NCT03274453View on ClinicalTrials.gov

A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion

PHASE2CompletedINTERVENTIONAL

Enrollment

129

Participants

Timeline

Start Date

November 1, 2012

Primary Completion Date

November 1, 2014

Study Completion Date

September 30, 2017

Conditions

Spinal Fusion

Interventions

DRUG

Ketamine

0.12 mg/kg/hr of ketamine post surgery

DRUG

Saline

Saline will be administered at the same rate as the ketamine infusion.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT03274453 - A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion | Biotech Hunter | Biotech Hunter